Louisiana expands telehealth access for weight-loss medications

The sponsor of the Senate bill that lifted the telehealth restriction said the change is important because Louisiana continues to face one of the nation's highest obesity rates. According to data from the Centers for Disease Control and Prevention, about 40% of Louisiana adults are obese, meaning they have a body mass index (BMI) of at least 30. The state ranks third nationally for obesity prevalence.

While telehealth may increase access to treatment, some healthcare providers caution that virtual care works best when combined with traditional office visits.

Dr. Maurie Patterson-Rosen of Willis Knighton's Metabolic Disease and Obesity Clinic said telehealth offers significant convenience and can help patients stay engaged with their treatment plans.

"It does offer convenience, and you can follow people more frequently, which sometimes helps when you're trying to make lifestyle changes," Patterson-Rosen said.

However, she noted that telehealth also has limitations.

"You can't do a physical exam, you can't do lab work. You can certainly order lab work and have the patient follow up for that, but you can't do imaging studies," she said.

Patterson-Rosen said monitoring patients in person can be important because some risks associated with weight-loss medications and obesity treatment — including renal insufficiency, vitamin deficiencies and loss of muscle mass  —may be easier to detect during office visits. Tracking medication side effects and adjusting treatment plans also may be more effective through face-to-face evaluations.

Even with those limitations, supporters of the law change argue that expanding access to obesity treatment could benefit public health. As advances in artificial intelligence and robotics continue to reshape daily life and potentially contribute to more sedentary lifestyles, increasing access to weight-management tools may help more people maintain healthier weights and reduce obesity-related health risks.